Last Updated: September 29, 2026

Litigation Details for Skandia Mutual Life Insurance Co. v. Viatris Inc. (S.D.N.Y. 2021)

✉ Email this page to a colleague

« Back to Dashboard

Skandia Mutual Life Insurance Co. v. Viatris Inc. (S.D.N.Y. 2021)

Docket	1:21-cv-01333	Date Filed	2021-02-15
Court	District Court, S.D. New York	Date Terminated	2025-04-29
Cause	15:78j(b)ss Stockholder Suit	Assigned To	James Paul Oetken
Jury Demand	Plaintiff	Referred To
Patents	7,449,012; 7,794,432; 8,048,035; 8,870,827
Link to Docket	External link to docket

Small Molecule Drugs cited in Skandia Mutual Life Insurance Co. v. Viatris Inc.

The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .

Details for Skandia Mutual Life Insurance Co. v. Viatris Inc. (S.D.N.Y. 2021)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2021-02-15				External link to document
2021-02-14	1	Complaint	expiration of U.S. Patent Nos. 7,449,012 B2 (the “’012 patent”) and 7,794,432 B2 (the “’432 patent”), which expire…Numbers 7,449,012, 7,794,432, 8,048,035, and 8,870,827 (the “EpiPen Patents”). These four patents have a priority…) in 2007. There are numerous patents covering the EpiPen. These patents do not expire until September…additional patents for features that were subsequently integrated into the EpiPen: U.S. Patent Numbers …The issuance of the EpiPen Patents, and Mylan’s designation of these patents as covering the EpiPen, further	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.